|
06 Sep 2013 |
Prosensa Initiates First Patient Dosing in Phase I/II trial of PRO053
|
|
05 Sep 2013 |
Adynxx Completes Patient Enrollment in Phase 2 Clinical Study of Lead Therapeutic for Prevention of Pain, AYX1
|
|
04 Sep 2013 |
SanBio Announces The Completion Of Enrollment Of Its Clinical Trial Of Cell Therapy For Chronic Stroke Deficits
|
|
31 Aug 2013 |
Isis Reports Interim Phase 2 Data on ISIS-APOCIII Rx as a Single Agent in Patients With Very High to Severely High Triglycerides
|
|
30 Aug 2013 |
Ophthotech Enrolls First Patient in Phase 3 Clinical Trial of Fovista™ Anti-PDGF Therapy in Combination with Anti-VEGF Therapy for Wet AMD
|
|
29 Aug 2013 |
Alnylam and Collaborators Publish Clinical Trial Results with RNAi Therapeutics Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR) in the New England Journal of Medicine
|
|
27 Aug 2013 |
OncoGenex Announces that the Rainier™ Clinical Trial Evaluating Apatorsen (OGX-427) in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer is Now Open for Enrollment
|
|
27 Aug 2013 |
Oncolytic Virus Specialist Virttu Biologics Confirms Treatment of First Cohort of Patients in Phase I/II SEPREHVIR(R) Study in Mesothelioma
|
|
21 Aug 2013 |
Avita Medical Announces Completion of Enrollment in ReCell(R) Trial for Vitiligo
|
